26th July 2018

EKF secures Japanese contract

Penarth-headquartered medical diagnostic equipment provider EKF has secured a distribution deal with a Japanese counterpart to market a product in the US.

The product, proiduced by Japanese manufacturer Asahi Kasei, is used in measuring glycated albumin, a marker used to determine blood glucose control for patients with diabetes.

Measuring glycated albumin is also useful for pregnant women and patients with dialysis as well as patients with other conditions.

Under the distribution agreement EKF will undertake marketing, promotion and distribution of the product which will be manufactured by Asahi Kasei.

The product which is named Lucica GA will be sold through EKF’s established reagent sales network in the US and sold alongside EKF’s clinical chemistry products which are currently used in over 1,100 hospitals in the US.

Julian Baines, chief executive of EKF, said: “This US distribution deal is an exciting and original addition to our diabetes portfolio and will work really well alongside BhB.

“In addition the agreement will create an additional revenue line in our clinical chemistry portfolio and will utilise our already established US reagent sales channel. We look forward to working with Asahi Kasei to promote a new option of glycemic control to diabetes patients and to healthcare professionals.”

View EKF’s profile here.